Non Invasive Monitoring Systems Inc

Non-Invasive Monitoring Systems, Inc. (OTC: NIMU) is a Florida corporation incorporated on July 16, 1980, and headquartered at 4400 Biscayne Boulevard in Miami, Florida, with a long history in medical technology development spanning more than four decades. The company was originally founded as a medical diagnostic monitoring company to develop computer-aided continuous monitoring devices for detecting abnormal respiratory and cardiac events using surface sensors placed on the human body — a category of patient monitoring technology that addresses the clinical need for non-invasive assessment of cardiopulmonary status in hospitalized patients, sleep medicine applications, and other settings where continuous physiological monitoring is clinically valuable without the need for invasive instrumentation.<br><br>The company subsequently pivoted from its original cardiac and respiratory monitoring focus to the development and marketing of its Exer-Rest line of acceleration therapeutic platforms, which are based upon the company's unique patented Whole Body Periodic Acceleration (WBPA) technology. WBPA therapy involves the rhythmic, horizontal oscillation of a patient lying on a specialized platform, with the mechanical acceleration forces delivered to the body stimulating the release of vasodilatory and anti-inflammatory compounds including nitric oxide from the vascular endothelium. This mechanism of action has been studied for potential therapeutic applications in cardiovascular conditions, peripheral vascular disease, and other conditions where nitric oxide-mediated vasodilation and endothelial function may play a role in patient outcomes.<br><br>Non-Invasive Monitoring Systems, Inc. has licensed the rights to its technology and currently maintains limited administrative functions without active operational or revenue-generating activities. The company files periodic reports with the Securities and Exchange Commission, including quarterly Form 10-Q filings, and trades on the OTC market under the ticker symbol NIMU. The company's long history of medical technology development — from cardiac monitoring to therapeutic acceleration platforms — reflects the evolution of its intellectual property portfolio across multiple decades of medical innovation, even as the company's current operational scope has contracted to minimal administrative maintenance activities.